AI Coming for Pharmacy Benefit Managers: Winners and Losers
Artificial intelligence is accelerating the disruption of pharmacy benefit managers, reshaping margins and creating n...
Auto rebalancing and capital gains management covers how automated tweaks can curb tax impact while preserving strategy.
28,655 articlesArtificial intelligence is accelerating the disruption of pharmacy benefit managers, reshaping margins and creating n...
On a midweek session, robinhood stock crushed wednesday surged as investors absorbed a potential crypto policy shift ...
When a biotech deal moves a small cap, it can set the tone for the whole sector. This story explains what happened wi...
Morph will host USDC and Circle's Cross-Chain Transfer Protocol, enabling standardized, cross-chain settlement for pa...
President Trump taps Bill Pulte to serve as Acting Director of National Intelligence while keeping him at the helm of...
The AI boom is entering a new phase, moving beyond a single hardware star. This guide explores who stands to gain, ho...
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Palantir is navigating a mix of headwinds and catalysts as 2026 unfolds. Here are three grounded predictions palantir...
Late Saturday, gunfire near the White House prompted a rapid security response. Authorities reported no injuries, whi...
AGNC Investment's more than 13.5% yield looks tempting, especially in a low-rate world. Yet looming Fed rate changes ...
Demi Moore reportedly lands a top per-episode rate, highlighting how big contracts affect seasons, taxes, and long-te...
OpenAI's planned IPO faces a timing change that could redefine AI stock bets. The shift underscores a tougher funding...